Christelle Johnson

Company: Personalis Inc

Seminars:

ImmunoID NeXT: A Comprehensive Platform for Immuno- Oncology – Improving Neoantigen Prediction, Evaluating Tumor Dynamics, and Immunogenomics Profiling 2:30 pm

Accurate assessment of mutational landscape and putative neoantigens from the analytically-validated exome and transcriptome ImmunoID NeXT platform Improved neoantigen presentation and binding predictions through a machine learning algorithm, SHERPA, built upon high quality immunopeptidomics training data from mono-allelic, and multi-allelic samples Comprehensive immunogenomics profiling from a single sample to guide neoantigen-based therapies and biomarker discoveryRead more

day: Day One